These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 22964051)
1. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening? Maurer HH J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051 [TBL] [Abstract][Full Text] [Related]
2. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening]. Li XW; Shen BH; Zhuo XY Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869 [TBL] [Abstract][Full Text] [Related]
4. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control. Maurer HH J Mass Spectrom; 2006 Nov; 41(11):1399-413. PubMed ID: 17051522 [TBL] [Abstract][Full Text] [Related]
5. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Maurer HH Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802 [TBL] [Abstract][Full Text] [Related]
6. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology. Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997 [TBL] [Abstract][Full Text] [Related]
7. Multiple stage MS in analysis of plasma, serum, urine and in vitro samples relevant to clinical and forensic toxicology. Meyer GM; Maurer HH; Meyer MR Bioanalysis; 2016; 8(5):457-81. PubMed ID: 26924594 [TBL] [Abstract][Full Text] [Related]
8. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling. Shou WZ; Zhang J Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321 [TBL] [Abstract][Full Text] [Related]
9. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review. Peters FT; Remane D Anal Bioanal Chem; 2012 Jun; 403(8):2155-72. PubMed ID: 22549818 [TBL] [Abstract][Full Text] [Related]
10. Recent applications of liquid chromatography-mass spectrometry in forensic science. Wood M; Laloup M; Samyn N; del Mar Ramirez Fernandez M; de Bruijn EA; Maes RA; De Boeck G J Chromatogr A; 2006 Oct; 1130(1):3-15. PubMed ID: 16716330 [TBL] [Abstract][Full Text] [Related]
11. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Peters FT Clin Biochem; 2011 Jan; 44(1):54-65. PubMed ID: 20709050 [TBL] [Abstract][Full Text] [Related]
12. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Ojanperä I; Kolmonen M; Pelander A Anal Bioanal Chem; 2012 May; 403(5):1203-20. PubMed ID: 22302167 [TBL] [Abstract][Full Text] [Related]
13. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Maurer HH Clin Biochem; 2005 Apr; 38(4):310-8. PubMed ID: 15766732 [TBL] [Abstract][Full Text] [Related]
14. Analysis of 18 perfluorinated compounds in river waters: comparison of high performance liquid chromatography-tandem mass spectrometry, ultra-high-performance liquid chromatography-tandem mass spectrometry and capillary liquid chromatography-mass spectrometry. Onghena M; Moliner-Martinez Y; Picó Y; Campíns-Falcó P; Barceló D J Chromatogr A; 2012 Jun; 1244():88-97. PubMed ID: 22633866 [TBL] [Abstract][Full Text] [Related]
15. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies. Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375 [TBL] [Abstract][Full Text] [Related]
16. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry. Arnhard K; Gottschall A; Pitterl F; Oberacher H Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975 [TBL] [Abstract][Full Text] [Related]
17. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry. Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069 [TBL] [Abstract][Full Text] [Related]
18. Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology. Schwaninger AE; Meyer MR; Maurer HH J Chromatogr A; 2012 Dec; 1269():122-35. PubMed ID: 22858363 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of drug screening in forensic autopsy: retrospective investigation of routine toxicological findings. Tominaga M; Michiue T; Inamori-Kawamoto O; Hishmat AM; Oritani S; Takama M; Ishikawa T; Maeda H Leg Med (Tokyo); 2015 May; 17(3):172-6. PubMed ID: 25637163 [TBL] [Abstract][Full Text] [Related]
20. Systematic forensic toxicological analysis by liquid-chromatography-quadrupole-time-of-flight mass spectrometry in serum and comparison to gas chromatography-mass spectrometry. Grapp M; Kaufmann C; Streit F; Binder L Forensic Sci Int; 2018 Jun; 287():63-73. PubMed ID: 29649771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]